Gramley, F; Himmrich, E; Mollnau, H et al.
RECENT ADVANCES IN THE PHARMACOLOGICAL TREATMENT OF CARDIAC ARRHYTHMIASDRUGS OF TODAY. Bd. 45. H. 11. 2009 S. 807-824
Foller, M; Sopjani, M; Koka, S et al.
Regulation of erythrocyte survival by AMP-activated protein kinase.FASEB J. Bd. 23. H. 4. 2009 S. 1072-80
Schnabel, RB; Larson, MG; Yamamoto, JF et al.
Relation of Multiple Inflammatory Biomarkers to Incident Atrial FibrillationAMERICAN JOURNAL OF CARDIOLOGY. Bd. 104. H. 1. 2009 S. 92-96
Sinning, C; Keller, T; Blankenberg, S
Role of biomarkers for risk stratification in the prevention of cardiovascular diseasesDEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. Bd. 134. H. 40. 2009 S. 2019-2022
Liuni, A; Luca, MC; Gori, T et al.
Rosuvastatin Prevents Ischemia and Reperfusion-Induced Endothelial Dysfunction by a COX-2 Dependent MechanismCIRCULATION. Bd. 120. H. 18. 2009 S. S1108-S1108
Keller, T; Zeller, T; Peetz, D et al.
Sensitive Troponin I Assay in Early Diagnosis of Acute Myocardial Infarction.NEW ENGLAND JOURNAL OF MEDICINE. Bd. 361. H. 9. 2009 S. 868-877
Xia, N; Daiber, A; Habermeier, A et al.
SIRT1 as a regulator of cardiovascular oxidative stressNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 379. 2009 S. 21-22
Xia, N; Daiber, A; Habermeier, A et al.
SIRT1-Dependent and -Independent Effects of Resveratrol on Cardiovascular Oxidative StressCIRCULATION. Bd. 120. H. 18. 2009 S. S1085-S1085
Gori, T; Munzel, T
Symptomatic and hemodynamic benefit of pentaerythrityl tetranitrate and hydralazine in a case of congestive heart failureCLINICAL RESEARCH IN CARDIOLOGY. Bd. 98. H. 10. 2009 S. 677-679
Forconi, S; Gori, T
The evolution of the meaning of blood hyperviscosity in cardiovascular physiopathology: should we reinterpret Poiseuille?Clin Hemorheol Microcirc. Bd. 42. H. 1. 2009 S. 1-6